Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Dr. Prem Aggarwal

Dr Prem Aggarwal, (MD Medicine, DNB Cardiology) is a Cardiologist by profession and also the Co-founder and Chairman of Medical Dialogues. He focuses on news and perspectives about cardiology, and medicine related developments at Medical Dialogues. He can be reached out at drprem@medicaldialogues.in

Home

Dr. Prem Aggarwal

Articles By : Dr. Prem Aggarwal

Finerenone Benefits Heart Failure Patients Regardless of Frailty Status: JAMA

Dr. Prem Aggarwal24 Jun 2025 8:00 AM IST

UK: A new analysis of the FINEARTS-HF clinical trial reveals that finerenone, a nonsteroidal mineralocorticoid receptor antagonist, offers significant...

High Triglycerides Drive Residual Cardiovascular Risk Despite Optimal Lipid-Lowering Therapy: Study Shows

Dr. Prem Aggarwal24 Jun 2025 7:45 AM IST

Netherlands: A new study published in Atherosclerosis reveals that elevated triglyceride (TG) levels are strongly associated with an increased risk of...

CMR-Derived ECV Predicts Long-Term Risk of MACE in 'True' MINOCA Patients: Study

Dr. Prem Aggarwal23 Jun 2025 8:45 AM IST

China: Cardiac MRI-derived extracellular volume (ECV) levels vary based on the underlying cause of myocardial infarction with non-obstructive coronary...

Frailty Significantly Increases Mortality and Complications in PCI Patients, NCDR Registry Study Finds

Dr. Prem Aggarwal21 Jun 2025 8:00 AM IST

USA: Frailty is common among older patients undergoing percutaneous coronary intervention (PCI) in the United States, with greater frailty linked to...

Enlicitide Decanoate Promising as Oral PCSK9 Inhibitor in Hyperlipidemia in Phase 3 trials

Dr. Prem Aggarwal21 Jun 2025 7:30 AM IST

Phase 3 trials have demonstrated that enlicitide decanoate significantly reduces LDL cholesterol, showing strong potential as an oral PCSK9 inhibitor...

Higher Dietary Selenium Intake Linked to Reduced Cardiovascular Disease Risk: Study

Dr. Prem Aggarwal20 Jun 2025 8:45 AM IST

A new study published in the recent issue of Nature Scientific Reports showed that increased dietary selenium intake is linked to a lower risk of...

Targeting SBP Below 130 mmHg May Lower Hospitalizations in HFpEF Without Increasing Serious Risks: Meta-analysis

Dr. Prem Aggarwal19 Jun 2025 8:45 AM IST

Japan: Targeting a systolic blood pressure (SBP) below 130 mmHg may significantly reduce hospitalizations in patients with heart failure with...

Cool Drinks Linked to Afib Episodes: Survey Finds Lifestyle Impact

Dr. Prem Aggarwal19 Jun 2025 8:30 AM IST

USA: Researchers have found in a cross-sectional survey that many individuals with atrial fibrillation (AFib) experienced fewer episodes by avoiding...

Cannabis use linked to doubling in risk of cardiovascular disease death: Study

Dr. Prem Aggarwal18 Jun 2025 5:00 AM IST

Cannabis use is linked to a doubling in the risk of dying from cardiovascular disease, with significantly heightened risks of having a stroke or acute...

Atrial Fibrillation Linked to Fourfold Rise in Cardiac Arrest Risk Among HFpEF Patients: Study Shows

Dr. Prem Aggarwal17 Jun 2025 9:00 AM IST

USA: Atrial fibrillation (AF) substantially heightens the risk of life-threatening arrhythmias and cardiac arrest in individuals with heart failure...

Preserving good cardiovascular health lowers the risk of mortality and MAFLD: Study

Dr. Prem Aggarwal17 Jun 2025 8:15 AM IST

A new study published in the journal of Nature Scientific Reports showed that high Life's Essential 8 (LE8) scores were related to a 90% reduction in...

Post-PCI De-escalation of Ticagrelor to Clopidogrel Reduces Bleeding Risk Without Increasing Ischemic Events in CKD Patients: JAMA

Dr. Prem Aggarwal16 Jun 2025 8:45 AM IST

A new study published in the Journal of American Medical Association showed that switching from ticagrelor to clopidogrel one month after percutaneous...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok